Deutsche Bank’s Nemaura Medical, Inc. Common Stock NMRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-4,800
Closed -$37K 4862
2021
Q1
$37K Sell
4,800
-450
-9% -$2.98K ﹤0.01% 4303
2020
Q4
$20K Buy
5,250
+1,839
+54% +$7.09K ﹤0.01% 4245
2020
Q3
$12K Buy
3,411
+318
+10% +$1.86K ﹤0.01% 4180
2020
Q2
$29K Buy
+3,093
New +$22.1K ﹤0.01% 3998
2020
Q1
Sell
-300
Closed -$1K 4956
2019
Q4
$1K Buy
+300
New +$1.84K ﹤0.01% 4945
2019
Q2
Sell
-3,464
Closed -$35K 5574
2019
Q1
$35K Buy
3,464
+2,833
+449% +$29.9K ﹤0.01% 4667
2018
Q4
$5K Buy
631
+601
+2,003% +$10.8K ﹤0.01% 4990
2018
Q3
$1K Buy
+30
New +$745 ﹤0.01% 5312

Other funds holding NMRD

Deutsche Bank's NMRD Position: Q2 2021 in Review

Deutsche Bank sold out of Nemaura Medical, Inc. Common Stock (NMRD) in Q2 2021, closing a stake of 4,800 shares — an estimated $37K sold.

Deutsche Bank first reported a position in NMRD in Q3 2018 and held it in 8 quarters. The position peaked at $37K in Q1 2021. 29 funds tracked by Wall St. Rank hold NMRD as of Q2 2021.

  • Deutsche Bank reported no remaining Nemaura Medical, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Deutsche Bank sold 4,800 Nemaura Medical, Inc. Common Stock shares in Q2 2021, an estimated $37K.
  • Deutsche Bank first reported a position in Nemaura Medical, Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Deutsche Bank's Nemaura Medical, Inc. Common Stock position peaked at $37K in Q1 2021.
  • 29 funds tracked by Wall St. Rank held Nemaura Medical, Inc. Common Stock as of Q2 2021.

Based on Deutsche Bank's 13F filing for Q2 2021, filed 11 Aug 2021.